Latest European Union News

Anatara Lifesciences reports Phase II GaRP-IBS trial results showing no safety concerns but missing the primary efficacy endpoint, while securing key patents and receiving a significant R&D tax refund.

Elementos Limited has delivered a robust Definitive Feasibility Study for its Oropesa Tin Project in Spain, secured a $5 million strategic investment from Metals X, and progressed exploration at its Cleveland Tin Project in Tasmania.

Osmond Resources has confirmed the award of the Orión Investigation Permit in Spain and is set to begin an initial drilling program this quarter, advancing its EU Critical Minerals Project amid strong regulatory support.

LTR Pharma has initiated commercial distribution of its nasal spray SPONTAN through Australia's Symbion pharmacy network and is advancing ROXUS development for a US launch in early 2026, while expanding its pipeline with a new intranasal treatment for swallowing disorders.

Carnegie Clean Energy's subsidiary has secured two milestone payments totaling approximately AUD 520,000, marking significant progress in deploying its wave energy technology at a key European test site.

Osmond Resources has verified monazite as the dominant rare earth mineral at its Orión Project in Spain, highlighting elevated levels of critical magnetic rare earth elements. A maiden drilling program and ongoing metallurgical testing aim to advance the project as a strategic EU supply source.

Osteopore Limited has gained Swiss market approval for its 3D-printed bioresorbable implants under the EU Medical Device Regulation, completing its European product portfolio and strengthening its partnership with Zimmer Biomet.

DroneShield is investing $13 million to significantly expand its R&D and manufacturing footprint, aiming to boost annual production capacity nearly fivefold by the end of 2026.

Osmond Resources has significantly expanded its Orion EU Critical Minerals Project by 160%, with promising assay results and a planned drilling program to confirm mineral continuity. The company is positioning itself to benefit from strong EU demand for rare earths, titanium, and silicon metals.

Anatara Lifesciences has strengthened its intellectual property portfolio with a Japanese patent for its GaRP gastrointestinal health product, while progressing pre-clinical studies in its Anti-Obesity Project. The company also confirmed registration of its R&D Tax Incentive application for 2024-2025.

Omni Bridgeway confirms the US Budget Bill signed on 4 July 2025 excludes the proposed Legal Finance tax, a move welcomed by the company amid broad political support.

Battery Age Minerals has initiated its first diamond drilling campaign at the Bleiberg Zinc-Lead-Germanium Project in Austria, aiming to unlock high-grade critical minerals essential for advanced technologies and European supply security.